# NOREPINEPHRINE BITARTRATE
> **ANDA214323** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2021-05-06
## Drug
- **FDA Application Number:** ANDA214323
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NOREPINEPHRINE BITARTRATE
- **Generic name:** NOREPINEPHRINE BITARTRATE
- **Active ingredients:** NOREPINEPHRINE BITARTRATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2021-05-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214323)
---
*AI Analytics · CC0 1.0*